Levodopa response in Parkinsonism with multiple mitochondrial DNA deletions

Movement Disorders

Volumn 22, Issue 7, 2007, Pages 1020-1023

  Wilcox, Robert A ^a,d   Churchyard, Andrew ^b   Dahl, Henrik H ^c   Hutchison, Wendy M ^c   Kirby, Denise M ^c   Thyagarajan, Dominic ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b Cabini Medical Centre   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

Chronic progressive external ophthalmoplegia; Mitochondrial disease; Neuropathy; Parkinson's disease; Parkinsonism

Indexed keywords

LEVODOPA; MITOCHONDRIAL DNA; VALPROIC ACID;

ADULT; ARTICLE; ATAXIA; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL FEATURE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG RESPONSE; DYSKINESIA; DYSMETRIA; FEMALE; FLAPPING TREMOR; GENE DELETION; HUMAN; LINKAGE ANALYSIS; MICROSATELLITE MARKER; MOTOR DYSFUNCTION; MOTOR FLUCTUATION; PARKINSON DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SYMPTOM; TREMOR;

ADULT; ANTIPARKINSON AGENTS; CHROMOSOME DELETION; DNA, MITOCHONDRIAL; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; PHARMACOGENETICS;

EID: 34347211798     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21416     Document Type: Article

References (13)

1. DiMauro S, Schon EA. Mitochondrial respiratory-chain disease. N Engl J Med 2003;348:2656-2668.
2. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene 2006;354:162-168.
3. Thyagarajan D. Mitochondrial disease. In: Noseworthy JH, editor. Neurological therapeutics principles and practice. Rochester, MN: Informa Healthcare; 2006. p 1743-1758.
4. Chinnery PF, Schon EA. Mitochondria. J Neurol Neurosurg Psychiatry 2003;74:1118-1199.
5. Thyagarajan D, Bressman S, Bruno C, et al. A novel mitochondrial 12SrRNA point mutation in Parkinsonism, deafness and neuropathy. Ann Neurol 2000;48:730-736.
6. Rana M, Coo I, Diaz F, Smeets H, Moraes CT. An out-of-frame cytochrome b gene deletion from a patient with parkinsonism is associated with impaired complex III assembly and an increase in free radical production. Ann Neurol 2000;48:774-781.
7. Chalmers RM, Brockington M, Howard RS, Lecky BRF, Morgan-Hughes JA, Harding AE. Mitochondrial encephalomyopathy with multiple mitochondrial DNA deletions: a report of two families and two sporadic cases with unusual clinical and neuropathological features. J Neurol Sci 1996;143:41-45.
8. Abou-Sleiman PM, Muqit MMK, Wood NW. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nature Rev 2006;7:207-219.
9. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson Disease. Nat Genet 2006;38:515-517.
10. Kraytsberg Y, Kudryavtseva E, McKee AC, Geula G, Kowall NW, Khrapko K. Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons. Nat Genet 2006;38:518-520.
11. Kirby DM, Crawford M, Cleary MA, Dahl H-HM, Dennett X, Thorburn DR. Respiratory chain complex I deficiency: An underdiagnosed energy generation disorder. Neurology 1999;52:1255-1264.
12. Lewis S, Hutchison W, Thyagarajan D, Dahl H-H. Clinical and molecular features of adPEO due to mutations in the twinkle gene. J. Neurol Sci 2002;201:39-44.
13. Berciano J, Valldeoriola F, Ferrer I, et al. Presynaptic parkinsonism in multiple system atrophy mimicking Parkinson's disease: a clinicopathological case study. Mov Disord 2002;17:812-816.